BRIEF: MedBot revenue doubles in 2025 on strong overseas gains
Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) on Wednesday said it expects to report its revenue last year rose by 110% to 120% from 2024 on growing traction for its…
BRIEF: MedBot reports strong year-to-date sales as commercialization accelerates
Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) said on Wednesday that cumulative orders for its core products, including laparoscopic, orthopedic, and vascular intervention surgical robots, surpassed 170 units as of…
